Rasagiline
- Product NDC
- 62135-677
- 11-digit product format
- 621350677
- Labeler code
- 62135
- Product ID
- 62135-677_17dd92b2-969b-16f1-e063-6394a90aee89
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rasagiline
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA201892
- Marketing category
- ANDA
- Marketing start
- 2018-07-27
- Substance
- RASAGILINE MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| LH8C2JI290 | RASAGILINE MESYLATE | 161735-79-1 | RASAGILINE MESYLATE |
| 003N66TS6T | RASAGILINE | 136236-51-6 | Rasagiline |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-677-30 | 62135067730 | 30 TABLET in 1 BOTTLE (62135-677-30) | 30 tablet | 2024-05-01 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Rasagiline | Chartwell RX, LLC | 2024-05-07 | HUMAN PRESCRIPTION DRUG LABEL | 1 |